CSTL Castle Biosciences, Inc.
Castle Biosciences, Inc. (CSTL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 82% planned / 18% discretionary
Largest single sale: $741.5K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Juvenal Tobin W | Chief Commercial Officer | Sell 10b5-1 | 1,730 | $32.81 | $56.8K | 65,184 −2.6% of holding | |
| MAETZOLD DEREK J 14 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 18,560 | $33.20 | $616.1K | 22,435 −45.3% of holding | |
| Oelschlager Kristen M 2 fills | Chief Operating Officer | Sell | 12,384 | $34.42 | $426.3K | 77,872 −13.7% of holding | |
| Juvenal Tobin W | Chief Commercial Officer | Sell 10b5-1 | 9,050 | $35.04 | $317.1K | 66,914 −11.9% of holding | |
| Oelschlager Kristen M | Chief Operating Officer | Sell | 12,218 | $33.69 | $411.6K | 85,033 −12.6% of holding | |
| Juvenal Tobin W | Chief Commercial Officer | Sell 10b5-1 | 1,730 | $29.59 | $51.2K | 75,964 −2.2% of holding | |
| Stokes Frank | Chief Financial Officer | Sell | 24,908 | $29.77 | $741.5K | 35,177 −41.5% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 7,232 | $30.02 | $217.1K | 21,479 −25.2% of holding | |
| MAETZOLD DEREK J 3 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 3,575 | $30.68 | $109.7K | 23,069 −13.4% of holding | |
| MAETZOLD DEREK J 6 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 35,441 | $31.11 | $1.1M | 33,414 −51.5% of holding | |
| MAETZOLD DEREK J 3 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 18,493 | $30.35 | $561.3K | 31,781 −36.8% of holding | |
| Oelschlager Kristen M 3 fills | Chief Operating Officer | Sell 10b5-1 | 8,586 | $29.77 | $255.6K | 18,874 −31.3% of holding | |
| Juvenal Tobin W | Chief Commercial Officer | Sell 10b5-1 | 1,730 | $28.25 | $48.9K | 78,995 −2.1% of holding | |
| Juvenal Tobin W 3 fills | Chief Commercial Officer | Sell 10b5-1 | 17,310 | $29.31 | $507.3K | 89,886 −16.1% of holding | |
| MAETZOLD DEREK J 3 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 10,153 | $30.15 | $306.1K | 36,013 −22% of holding | |
| MAETZOLD DEREK J 14 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 9,836 | $24.16 | $237.7K | 38,046 −20.5% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 4,172 | $22.92 | $95.6K | 39,353 −9.6% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 9,836 | $24.29 | $238.9K | 40,710 −19.5% of holding | |
| Oelschlager Kristen M 2 fills | Chief Operating Officer | Sell 10b5-1 | 8,586 | $24.42 | $209.7K | 22,274 −27.8% of holding | |
| Oelschlager Kristen M | Chief Operating Officer | Sell 10b5-1 | 8,587 | $20.71 | $177.8K | 30,460 −22% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 4,172 | $20.66 | $86.2K | 42,067 −9% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 9,836 | $20.86 | $205.1K | 43,424 −18.5% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 3,183 | $20.20 | $64.3K | 44,781 −6.6% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 989 | $20.00 | $19.8K | 45,816 −2.1% of holding | |
| MAETZOLD DEREK J 14 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 9,836 | $22.15 | $217.9K | 46,336 −17.5% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 4,172 | $25.10 | $104.7K | 47,495 −8.1% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 9,836 | $25.03 | $246.2K | 48,852 −16.8% of holding | |
| MAETZOLD DEREK J 7 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 4,172 | $25.55 | $106.6K | 50,209 −7.7% of holding | |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell 10b5-1 | 650 | $25.39 | $16.5K | 21,479 −2.9% of holding | |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Sell 10b5-1 | 18,650 | $25.93 | $483.6K | 22,129 −45.7% of holding | |
| MAETZOLD DEREK J 2 fills | Pres. & Chief Exec. Officer | Sell 10b5-1 | 17,575 | $25.97 | $456.4K | 40,905 −30.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.